XML 40 R28.htm IDEA: XBRL DOCUMENT v3.25.3
Income Taxes (Tables)
 9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information

 Schedule of Segment Reporting Information

Segment Reporting for the Three Months Ended September 30, 2025

 

                          
   Treatment   Services   Segments Total   Corporate (1)   Consolidated Total 
Revenue from external customers  $13,114   $4,340   $17,454   $—   $17,454 
Cost of Goods Sold:                         
Payroll and benefits expenses   4,809    2,358    7,167    —    7,167 
Material and supplies expenses   2,158    —    2,158    —    2,158 
Disposal expenses   1,075    —    1,075    —    1,075 
Transportation expenses   361    —    361    —    361 
Subcontract expenses   —    118    118    —    118 
Other cost of goods sold (2)   2,445    1,573    4,018    —    4,018 
Total cost of goods sold   10,848    4,049    14,897    —    14,897 
Gross profit   2,266    291    2,557    —    2,557 
SG&A:                         
Payroll and benefits   947    547    1,494    997    2,491 
Other SG&A (3)   386    199    585    1,007    1,592 
Total SG&A   1,333    746    2,079    2,004    4,083 
Research and development   257    2    259    83    342 
Loss on disposal of property and equipment   4    —    4    —    4 
Income (loss) from operations  $672   $(457)  $215   $(2,087)   (1,872)
Interest income                       266 
Interest expense                       (116)
Interest expense-financing fees                       (22)
Other expense                       (18)
Loss from continuing operations before taxes                       (1,762)
Income tax expense                       — 
Loss from continuing operations, net of taxes                      $(1,762)

 

Segment Reporting for the Three Months Ended September 30, 2024

 

                          
   Treatment   Services   Segments Total   Corporate (1)   Consolidated Total 
Revenue from external customers  $9,064   $7,748   $16,812   $—   $16,812 
Cost of goods sold:                         
Payroll and benefit expenses   4,275    2,636    6,911    —    6,911 
Material and supplies expenses   1,035    —    1,035    —    1,035 
Disposal expenses   788    —    788    —    788 
Transportation expenses   322    —    322    —    322 
Subcontract expenses   —    2,135    2,135    —    2,135 
Other cost of goods sold (2)   2,234    2,053    4,287    —    4,287 
Total cost of goods sold   8,654    6,824    15,478    —    15,478 
Gross profit   410    924    1,334    —    1,334 
SG&A:                         
Payroll and benefits   743    643    1,386    848    2,234 
Other SG&A (3)   341    172    513    885    1,398 
Total SG&A   1,084    815    1,899    1,733    3,632 
Research and development   205    34    239    64    303 
(Loss) income from operations  $(879)  $75   $(804)  $(1,797)   (2,601)
Interest income                       292 
Interest expense                       (121)
Interest expense-financing fees                       (18)
Other income                       59 
Loss from continuing operations before taxes                       (2,389)
Income tax expense                       6,417 
Loss from continuing operations, net of taxes                      $(8,806)

 

 

Segment Reporting for the Nine Months Ended September 30, 2025

 

                          
   Treatment   Services   Segments Total   Corporate (1)   Consolidated Total 
Revenue from external customers  $33,696   $12,263   $45,959   $—   $45,959 
Cost of Goods Sold:                         
Payroll and benefits expenses   13,988    6,245    20,233    —    20,233 
Material and supplies expenses   4,744    —    4,744    —    4,744 
Disposal expenses   2,391    —    2,391    —    2,391 
Transportation expenses   1,222    —    1,222    —    1,222 
Subcontract expenses   —    1,184    1,184    —    1,184 
Other cost of goods sold (2)   7,269    4,155    11,424    —    11,424 
Total cost of goods sold   29,614    11,584    41,198    —    41,198 
Gross profit   4,082    679    4,761    —    4,761 
SG&A:                         
Payroll and benefits   2,763    1,732    4,495    2,869    7,364 
Other SG&A (3)   1,276    573    1,849    3,015    4,864 
Total SG&A   4,039    2,305    6,344    5,884    12,228 
Research and development   780    29    809    228    1,037 
Loss (gain) on disposal of property and equipment   3    (5)   (2)   —    (2)
Loss from operations  $(740)  $(1,650)  $(2,390)  $(6,112)   (8,502)
Interest income                       901 
Interest expense                       (351)
Interest expense-financing fees                       (63)
Other income                       171 
Loss from continuing operations before taxes                       (7,844)
Income tax expense                       — 
Loss from continuing operations, net of taxes                      $(7,844)

 

Segment Reporting for the Nine Months Ended September 30, 2024

 

                          
   Treatment   Services   Segments Total   Corporate (1)   Consolidated Total 
Revenue from external customers  $26,116   $18,299   $44,415   $—   $44,415 
Cost of goods sold:                         
Payroll and benefit expenses   11,970    7,065    19,035    —    19,035 
Material and supplies expenses   2,876    —    2,876    —    2,876 
Disposal expenses   4,211    —    4,211    —    4,211 
Transportation expenses   837    —    837    —    837 
Subcontract expenses   —    6,498    6,498    —    6,498 
Other cost of goods sold (2)   7,061    4,489    11,550    —    11,550 
Total cost of goods sold   26,955    18,052    45,007    —    45,007 
Gross (loss) profit   (839)   247    (592)   —    (592)
SG&A:                         
Payroll and benefits   2,145    1,799    3,944    2,517    6,461 
Other SG&A (3)   1,079    474    1,553    2,617    4,170 
Total SG&A   3,224    2,273    5,497    5,134    10,631 
Research and development   609    87    696    176    872 
Loss on disposal of property and equiment   —    1    1    —    1 
Loss from operations  $(4,672)  $(2,114)  $(6,786)  $(5,310)   (12,096)
Interest income                       679 
Interest expense                       (346)
Interest expense-financing fees                       (47)
Other income                       61 
Loss from continuing operations before taxes                       (11,749)
Income tax expense                       4,300 
Loss from continuing operations, net of taxes                      $(16,049)

 

(1)Amounts reflect the activity for corporate headquarters not included in the segment reporting information.

 

(2)Other cost of goods sold for each reportable segment includes:

Treatment - lab, regulatory, repair and maintenance, depreciation and amortization, travel, outside services and general expenses.

Services - material and supplies, disposal, transportation, lab, regulatory, repair and maintenance, depreciation and amortization, travel, outside services and general expenses.

 

(3)Other SG&A for each reportable segment and Corporate includes:

Treatment-depreciation and amortization, travel, outside services, repair and maintenance and general expenses.

Services- travel, outside services, repair and maintenance and general expenses.

Corporate-repair and maintenance, depreciation and amortization, travel, public company, outside services and general expenses.
Schedule of Depreciation and Amortization

The following table presents depreciation and amortization for the three and nine months ended September 30, (in thousand):

 Schedule of Depreciation and Amortization

                     
   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2025   2024   2025   2024 
Treatment  $387   $370   $1,158   $1,104 
Services   28    44    109    133 
Total segment   415    414    1,267    1,237 
Corporate   11    19    32    58 
Total  $426   $433   $1,299   $1,295 
Schedule of Capital Expenditures

The following table presents capital expenditures for the three and nine months ended September 30, (in thousand):

 

Schedule of Capital Expenditures

                     
   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2025   2024   2025   2024 
Treatment  $1,145   $1,203   $2,525   $1,820 
Services   31    180    83    404 
Total segment   1,176    1,383    2,608    2,224 
Corporate   —    —    —    — 
Total  $1,176(1)  $1,383(2)  $2,608(1)  $2,224(2)

 

(1)Net of financed amount of $30 and $162 for the three and nine months ended September 30, 2025, respectively.

 

(2)Net of financed amount of $361 and $406 for the three and nine months ended September 30, 2024, respectively.